Evidence map›Paper›PMID 36988570›Full record

SynthesisThe journals of gerontology. Series A, Biological sciences and medical sciences2023

Mosaic Chromosomal Alterations and Human Longevity.

Anastasia Leshchyk, Qingyan Xiang, Stacy L Andersen, Anastasia Gurinovich, Zeyuan Song, Joseph H Lee, Kaare Christensen, Anatoliy Yashin, Mary Wojczynski, Karen Schwander and 3 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in The journals of gerontology. Series A, Biological sciences and medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Anastasia LeshchykBioinformatics Program, Boston University, Boston, Massachusetts, USA.ORCID 0000-0002-2830-6701
Qingyan XiangDepartment of Biostatistics, Boston University, Boston, Massachusetts, USA.
Stacy L AndersenDepartment of Medicine, Section of Geriatrics, Boston University, Boston, Massachusetts, USA.ORCID 0000-0002-2442-6386
Anastasia GurinovichInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.
Zeyuan SongDepartment of Biostatistics, Boston University, Boston, Massachusetts, USA.
Joseph H LeeTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, USA.
Kaare ChristensenDepartment of Public Health, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-5429-5292
Anatoliy YashinSocial Science Research Institute, Duke University, Durham, North Carolina, USA.
Mary WojczynskiDepartment of Genetics, Washington University in St. Louis, St. Louis, Missouri, USA.
Karen SchwanderDivision of Biostatistics, Washington University in St. Louis, St. Louis, Missouri, USA.
Thomas T PerlsDepartment of Medicine, Section of Geriatrics, Boston University, Boston, Massachusetts, USA.
Stefano MontiDepartment of Medicine, Computational Biomedicine Section, Boston University, Boston, Massachusetts, USA.
Paola SebastianiInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA.
Boston University · USWashington University in St. Louis · USColumbia University · USSocial Science Research Council · USTufts Medical Center · USTufts University · USUniversity of Southern Denmark · DK

Funding

The Long Life Family StudyU19AG063893 · NIA · WASHINGTON UNIVERSITY · PI PAOLA SEBASTIANI · 2019 to 2026
$125.4M
Systems BiologyU19AG023122 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI RICHARD A MILLER · 2004 to 2026
$102.6M
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategiesUH3AG064704 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PERLS, THOMAS T, SEBASTIANI, PAOLA · 2022 to 2025
$14.7M
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategiesUH2AG064704 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PERLS, THOMAS T, SEBASTIANI, PAOLA · 2019 to 2021
$9.4M
Integrative Omics to enhance therapeutics development for healthy agingUH3AG064706 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI MILLER, RICHARD A, SCHORK, NICHOLAS JOSEPH · 2021 to 2024
$3.3M
Protein Signatures of APOE2 and Cognitive AgingR01AG061844 · NIA · TUFTS MEDICAL CENTER · PI PERLS, THOMAS T, SEBASTIANI, PAOLA · 2018 to 2022
$3.1M
NIA NIH HHS R01 AG061844NIA NIH HHS U19 AG023122NIA NIH HHS U19 AG063893NIA NIH HHS UH2 AG064704NIA NIH HHS UH3 AG064704NIA NIH HHS UH3 AG064706
6 · The paper itself

Abstract

Mosaic chromosomal alterations (mCAs) are structural alterations associated with aging, cancer, cardiovascular disease, infectious diseases, and mortality. The distribution of mCAs in centenarians and individuals with familial longevity is poorly understood. We used MOsaic CHromosomal Alteration (MoChA) to discover mCAs in 2050 centenarians, offspring, and 248 controls from the New England Centenarian Study (NECS) and in 3 642 subjects with familial longevity and 920 spousal controls from the Long-Life Family Study (LLFS). We analyzed study-specific associations of somatic mCAs with age, familial longevity, the incidence of age-related diseases, and mortality and aggregated the results by meta-analysis. We show that the accumulation of mCAs > 100 KB increased to 102 years and plateaued at older ages. Centenarians and offspring accumulated fewer autosomal mCAs compared with controls (relative risk 0.637, p = .0147). Subjects with the APOE E4 allele had a 35.3% higher risk of accumulating autosomal mCAs (p = .002). Males were at higher risk for mCAs compared to females (male relative risk 1.36, p = 5.15e-05). mCAs were associated with increased hazard for cancer (hazard ratio 1.2) and dementia (hazard ratio 1.259) at a 10% false discovery rate. We observed a borderline significant association between mCAs and risk for mortality (hazard ratio 1.07, p = .0605). Our results show that the prevalence of individuals with mCAs does not continue to increase at ages >102 years and factors promoting familial longevity appear to confer protections from mCAs. These results suggest that limited mCA accumulation could be an important mechanism for extreme human longevity that needs to be investigated.

Indexed as

Cardiovascular DiseasesNeoplasmsAged, 80 and overAgingFemaleHumansLongevityMaleRiskAgingClonal hematopoiesisMosaicism

Identifiers

PMID36988570
PMCPMC10460554
OpenAlexW4361304009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.